Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
主要な著者: | Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D |
---|---|
フォーマット: | Conference item |
出版事項: |
2009
|
類似資料
-
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
著者:: Patmanathan, S.N., 等
出版事項: (2015) -
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
著者:: Anthony, D, 等
出版事項: (2014) -
The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
著者:: Stradner Martin H, 等
出版事項: (2011-12-01) -
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
著者:: Siyao Li, 等
出版事項: (2023-07-01) -
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
著者:: Masayo Aoki, 等
出版事項: (2020-01-01)